Assembly Biosciences (ASMB) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to -$9.2 million.
- Assembly Biosciences' Income towards Parent Company rose 433.79% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 553.13%. This contributed to the annual value of -$40.2 million for FY2024, which is 3438.13% up from last year.
- As of Q3 2025, Assembly Biosciences' Income towards Parent Company stood at -$9.2 million, which was up 433.79% from -$10.2 million recorded in Q2 2025.
- Assembly Biosciences' Income towards Parent Company's 5-year high stood at -$8.8 million during Q1 2025, with a 5-year trough of -$62.8 million in Q4 2021.
- For the 4-year period, Assembly Biosciences' Income towards Parent Company averaged around -$17.5 million, with its median value being -$11.2 million (2024).
- As far as peak fluctuations go, Assembly Biosciences' Income towards Parent Company crashed by 46145.12% in 2021, and later skyrocketed by 5210.03% in 2024.
- Assembly Biosciences' Income towards Parent Company (Quarter) stood at -$62.8 million in 2021, then skyrocketed by 82.54% to -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then increased by 11.02% to -$9.2 million in 2025.
- Its Income towards Parent Company was -$9.2 million in Q3 2025, compared to -$10.2 million in Q2 2025 and -$8.8 million in Q1 2025.